BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys. 2004;429:123-133. [PMID: 15313215 DOI: 10.1016/j.abb.2004.04.020] [Cited by in Crossref: 129] [Cited by in F6Publishing: 131] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Zou Q, Chen YF, Zheng XQ, Ye SF, Xu BY, Liu YX, Zeng HH. Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression. J Zhejiang Univ Sci B 2018;19:689-98. [PMID: 30178635 DOI: 10.1631/jzus.B1700219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 2009;11:3013-69. [PMID: 19496700 DOI: 10.1089/ars.2009.2541] [Cited by in Crossref: 339] [Cited by in F6Publishing: 302] [Article Influence: 28.3] [Reference Citation Analysis]
3 Caserta E, Egriboz O, Wang H, Martin C, Koivisto C, Pecót T, Kladney RD, Shen C, Shim KS, Pham T, Karikomi MK, Mauntel MJ, Majumder S, Cuitino MC, Tang X, Srivastava A, Yu L, Wallace J, Mo X, Park M, Fernandez SA, Pilarski R, La Perle KM, Rosol TJ, Coppola V, Castrillon DH, Timmers C, Cohn DE, O'Malley DM, Backes F, Suarez AA, Goodfellow P, Chamberlin HM, Macrae ER, Shapiro CL, Ostrowski MC, Leone G. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev 2015;29:1707-20. [PMID: 26302789 DOI: 10.1101/gad.262568.115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
4 Yoshioka J, Schreiter ER, Lee RT. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal. 2006;8:2143-2151. [PMID: 17034356 DOI: 10.1089/ars.2006.8.2143] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
5 Lennicke C, Rahn J, Lichtenfels R, Wessjohann LA, Seliger B. Hydrogen peroxide - production, fate and role in redox signaling of tumor cells. Cell Commun Signal 2015;13:39. [PMID: 26369938 DOI: 10.1186/s12964-015-0118-6] [Cited by in Crossref: 203] [Cited by in F6Publishing: 193] [Article Influence: 29.0] [Reference Citation Analysis]
6 Powis G, Kirkpatrick DL. Thioredoxin signaling as a target for cancer therapy. Current Opinion in Pharmacology 2007;7:392-7. [DOI: 10.1016/j.coph.2007.04.003] [Cited by in Crossref: 196] [Cited by in F6Publishing: 186] [Article Influence: 13.1] [Reference Citation Analysis]
7 Lam JB, Chow KH, Xu A, Lam KS, Liu J, Wong NS, Moon RT, Shepherd PR, Cooper GJ, Wang Y. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One 2009;4:e4968. [PMID: 19319191 DOI: 10.1371/journal.pone.0004968] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
8 Kamal AM, El-Hefny NH, Hegab HM, El-Mesallamy HO. Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study. Hematology 2016;21:567-75. [PMID: 27158980 DOI: 10.1080/10245332.2016.1173341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
9 Im JY, Lee KW, Woo JM, Junn E, Mouradian MM. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 2012;21:3013-24. [PMID: 22492997 DOI: 10.1093/hmg/dds131] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 12.6] [Reference Citation Analysis]
10 Ago T, Yeh I, Yamamoto M, Schinke-Braun M, Brown JA, Tian B, Sadoshima J. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal 2006;8:1635-50. [PMID: 16987018 DOI: 10.1089/ars.2006.8.1635] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
11 Mishra RR, Chaudhary JK, Bajaj GD, Rath PC. A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells. PLoS One 2011;6:e28433. [PMID: 22164291 DOI: 10.1371/journal.pone.0028433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
12 Prozorovski T, Schneider R, Berndt C, Hartung HP, Aktas O. Redox-regulated fate of neural stem progenitor cells. Biochim Biophys Acta 2015;1850:1543-54. [PMID: 25662818 DOI: 10.1016/j.bbagen.2015.01.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
13 Hui ST, Andres AM, Miller AK, Spann NJ, Potter DW, Post NM, Chen AZ, Sachithanantham S, Jung DY, Kim JK, Davis RA. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A 2008;105:3921-6. [PMID: 18322014 DOI: 10.1073/pnas.0800293105] [Cited by in Crossref: 150] [Cited by in F6Publishing: 151] [Article Influence: 10.7] [Reference Citation Analysis]
14 Raninga PV, Di Trapani G, Tonissen KF. The Multifaceted Roles of DJ-1 as an Antioxidant. Adv Exp Med Biol 2017;1037:67-87. [PMID: 29147904 DOI: 10.1007/978-981-10-6583-5_6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
15 Andreadou I, Efentakis P, Frenis K, Daiber A, Schulz R. Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases. Basic Res Cardiol 2021;116:44. [PMID: 34275052 DOI: 10.1007/s00395-021-00885-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Schwertassek U, Haque A, Krishnan N, Greiner R, Weingarten L, Dick TP, Tonks NK. Reactivation of oxidized PTP1B and PTEN by thioredoxin 1. FEBS J 2014;281:3545-58. [PMID: 24976139 DOI: 10.1111/febs.12898] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
17 Trachootham D, Zhang W, Huang P. Oxidative Stress and Drug Resistance in Cancer. In: Siddik ZH, Mehta K, editors. Drug Resistance in Cancer Cells. New York: Springer US; 2009. pp. 137-75. [DOI: 10.1007/978-0-387-89445-4_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Farina AR, Cappabianca L, Desantis G, Ianni ND, Ruggeri P, Ragone M, Merolle S, Tonissen KF, Gulino A, Mackay AR. Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. FEBS Letters 2011;585:3328-36. [DOI: 10.1016/j.febslet.2011.09.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ren X, Ma H, Qiu Y, Liu B, Qi H, Li Z, Kong H, Kong L. The downregulation of thioredoxin accelerated Neuro2a cell apoptosis induced by advanced glycation end product via activating several pathways. Neurochem Int 2015;87:128-35. [PMID: 26142569 DOI: 10.1016/j.neuint.2015.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
20 Matsushima Y, Nanri H, Nara S, Okufuji T, Ohta M, Hachisuka K, Ikeda M. Hindlimb unloading decreases thioredoxin-related antioxidant proteins and increases thioredoxin-binding protein-2 in rat skeletal muscle. Free Radical Research 2009;40:715-22. [DOI: 10.1080/10715760600580488] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Billiet L, Furman C, Larigauderie G, Copin C, Page S, Fruchart J, Brand K, Rouis M. Enhanced VDUP-1 gene expression by PPARγ agonist induces apoptosis in human macrophage. J Cell Physiol 2008;214:183-91. [DOI: 10.1002/jcp.21179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
22 Wang J, Yang H, Li W, Xu H, Yang X, Gan L. Thioredoxin 1 upregulates FOXO1 transcriptional activity in drug resistance in ovarian cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015;1852:395-405. [DOI: 10.1016/j.bbadis.2014.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
23 Leonarduzzi G, Sottero B, Poli G. Targeting tissue oxidative damage by means of cell signaling modulators: The antioxidant concept revisited. Pharmacology & Therapeutics 2010;128:336-74. [DOI: 10.1016/j.pharmthera.2010.08.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
24 Lim S, Ashida H, Watanabe R, Inai K, Kim YS, Mukougawa K, Fukuda H, Tomizawa K, Ushiyama K, Asao H, Tamoi M, Masutani H, Shigeoka S, Yodoi J, Yokota A. Production of biologically active human thioredoxin 1 protein in lettuce chloroplasts. Plant Mol Biol 2011;76:335-44. [PMID: 21290168 DOI: 10.1007/s11103-011-9745-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
25 Mohammadi F, Soltani A, Ghahremanloo A, Javid H, Hashemy SI. The thioredoxin system and cancer therapy: a review. Cancer Chemother Pharmacol 2019;84:925-35. [PMID: 31367788 DOI: 10.1007/s00280-019-03912-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
26 Yang B, Chen Q. Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer. Oxid Med Cell Longev 2021;2021:6545728. [PMID: 34484567 DOI: 10.1155/2021/6545728] [Reference Citation Analysis]
27 Maulik N, Das DK. Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta. 2008;1780:1368-1382. [PMID: 18206121 DOI: 10.1016/j.bbagen.2007.12.008] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
28 Fujino G, Noguchi T, Takeda K, Ichijo H. Thioredoxin and protein kinases in redox signaling. Semin Cancer Biol 2006;16:427-35. [PMID: 17081769 DOI: 10.1016/j.semcancer.2006.09.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 6.3] [Reference Citation Analysis]
29 Jo SH, Kim MY, Park JM, Kim TH, Ahn YH. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice. Diabetologia 2013;56:2723-32. [PMID: 24037087 DOI: 10.1007/s00125-013-3050-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
30 Mukherjee A, Westwell AD, Bradshaw TD, Stevens MF, Carmichael J, Martin SG. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study. Br J Cancer 2005;92:350-8. [PMID: 15655539 DOI: 10.1038/sj.bjc.6602338] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
31 Akaishi R, Fujishima F, Ishida H, Tsunokake J, Yamauchi T, Gokon Y, Ueki S, Fukutomi T, Okamoto H, Takaya K, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma. Esophagus 2022. [PMID: 34999996 DOI: 10.1007/s10388-021-00904-3] [Reference Citation Analysis]
32 Nadeau PJ, Charette SJ, Landry J. REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell 2009;20:3628-37. [PMID: 19570911 DOI: 10.1091/mbc.e09-03-0211] [Cited by in Crossref: 67] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
33 Zuo Z, Zhang P, Lin F, Shang W, Bi R, Lu F, Wu J, Jiang L. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation. J Cell Mol Med 2018;22:2430-41. [PMID: 29383839 DOI: 10.1111/jcmm.13541] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
34 Hopkins BD, Hodakoski C, Barrows D, Mense SM, Parsons RE. PTEN function: the long and the short of it. Trends Biochem Sci 2014;39:183-90. [PMID: 24656806 DOI: 10.1016/j.tibs.2014.02.006] [Cited by in Crossref: 155] [Cited by in F6Publishing: 153] [Article Influence: 19.4] [Reference Citation Analysis]
35 Fedoroff N. Redox regulatory mechanisms in cellular stress responses. Ann Bot 2006;98:289-300. [PMID: 16790465 DOI: 10.1093/aob/mcl128] [Cited by in Crossref: 107] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
36 Singh LP. Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy. J Clin Exp Ophthalmol 2013;4. [PMID: 24353900 DOI: 10.4172/2155-9570.1000287] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
37 Tao B, Cai W, Zhu Y. H2S Is a Promoter of Angiogenesis: Identification of H2S “Receptors” and Its Molecular Switches in Vascular Endothelial Cells. In: Moore PK, Whiteman M, editors. Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide. Cham: Springer International Publishing; 2015. pp. 137-52. [DOI: 10.1007/978-3-319-18144-8_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 Chen B, Nelin VE, Locy ML, Jin Y, Tipple TE. Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 2013;305:L389-95. [PMID: 23812635 DOI: 10.1152/ajplung.00432.2012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
39 D Annunzio V, Perez V, Mazo T, Muñoz MC, Dominici FP, Carreras MC, Poderoso JJ, Sadoshima J, Gelpi RJ. Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1. Oncotarget 2016;7:11889-98. [PMID: 26933812 DOI: 10.18632/oncotarget.7726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
40 Georgescu MM. PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. Genes Cancer. 2010;1:1170-1177. [PMID: 21779440 DOI: 10.1177/1947601911407325] [Cited by in Crossref: 230] [Cited by in F6Publishing: 223] [Article Influence: 20.9] [Reference Citation Analysis]
41 Kurosawa T, Nakamura H, Yamaura E, Fujino H, Matsuzawa Y, Kawashima T, Murayama T. Cytotoxicity induced by inhibition of thioredoxin reductases via multiple signaling pathways: Role of cytosolic phospholipase A 2 α-dependent and -independent release of arachidonic acid. J Cell Physiol 2009;219:606-16. [DOI: 10.1002/jcp.21703] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
42 Baker AF, Dragovich T, Tate WR, Ramanathan RK, Roe D, Hsu CH, Kirkpatrick DL, Powis G. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. J Lab Clin Med. 2006;147:83-90. [PMID: 16459166 DOI: 10.1016/j.lab.2005.09.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
43 Fares Amer N, Luzzatto Knaan T. Natural Products of Marine Origin for the Treatment of Colorectal and Pancreatic Cancers: Mechanisms and Potential. IJMS 2022;23:8048. [DOI: 10.3390/ijms23148048] [Reference Citation Analysis]
44 Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D’Agostino DM, Ciminale V. HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med. 2010;31:350-358. [PMID: 20332002 DOI: 10.1016/j.mam.2010.03.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
45 Agassandian M, Zhou J, Tephly LA, Ryan AJ, Carter AB, Mallampalli RK. Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP:phosphocholine cytidylyltransferase. J Biol Chem 2005;280:21577-87. [PMID: 15788406 DOI: 10.1074/jbc.M412409200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
46 Abdalbari FH, Telleria CM. The gold complex auranofin: new perspectives for cancer therapy. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00439-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
47 Alhawiti NM, Al Mahri S, Aziz MA, Malik SS, Mohammad S. TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook. Curr Drug Targets 2017;18:1095-103. [PMID: 28137209 DOI: 10.2174/1389450118666170130145514] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 17.0] [Reference Citation Analysis]
48 Jaganjac M, Milkovic L, Sunjic SB, Zarkovic N. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants (Basel) 2020;9:E1151. [PMID: 33228209 DOI: 10.3390/antiox9111151] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
49 Barthel A, Ostrakhovitch EA, Walter PL, Kampkötter A, Klotz LO. Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 2007;463:175-82. [PMID: 17509519 DOI: 10.1016/j.abb.2007.04.015] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
50 Raninga PV, Trapani GD, Tonissen KF. Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer. Oncoscience 2014;1:95-110. [PMID: 25593990 DOI: 10.18632/oncoscience.12] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
51 Matsuzawa A. Thioredoxin and redox signaling: Roles of the thioredoxin system in control of cell fate. Archives of Biochemistry and Biophysics 2017;617:101-5. [DOI: 10.1016/j.abb.2016.09.011] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 17.6] [Reference Citation Analysis]
52 Bermúdez Brito M, Goulielmaki E, Papakonstanti EA. Focus on PTEN Regulation. Front Oncol 2015;5:166. [PMID: 26284192 DOI: 10.3389/fonc.2015.00166] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
53 Berggren M, Sittadjody S, Song Z, Samira JL, Burd R, Meuillet EJ. Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells. Nutr Cancer 2009;61:322-31. [PMID: 19373605 DOI: 10.1080/01635580802521338] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
54 Tay EXY, Chia K, Ong DST. Epigenetic plasticity and redox regulation of neural stem cell state and fate. Free Radic Biol Med 2021;170:116-30. [PMID: 33684459 DOI: 10.1016/j.freeradbiomed.2021.02.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Zhang W, Zhu Y, Yu H, Liu X, Jiao B, Lu X. Libertellenone H, a Natural Pimarane Diterpenoid, Inhibits Thioredoxin System and Induces ROS-Mediated Apoptosis in Human Pancreatic Cancer Cells. Molecules 2021;26:E315. [PMID: 33435380 DOI: 10.3390/molecules26020315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Oh SE, Mouradian MM. Regulation of Signal Transduction by DJ-1. Adv Exp Med Biol 2017;1037:97-131. [PMID: 29147906 DOI: 10.1007/978-981-10-6583-5_8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
57 Barthel A, Klotz LO. Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol Chem 2005;386:207-16. [PMID: 15843166 DOI: 10.1515/BC.2005.026] [Cited by in Crossref: 67] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
58 Zhou J, Damdimopoulos AE, Spyrou G, Brüne B. Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha. J Biol Chem 2007;282:7482-90. [PMID: 17220299 DOI: 10.1074/jbc.M608289200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
59 Zhang Y, Park J, Han SJ, Yang SY, Yoon HJ, Park I, Woo HA, Lee SR. Redox regulation of tumor suppressor PTEN in cell signaling. Redox Biol 2020;34:101553. [PMID: 32413744 DOI: 10.1016/j.redox.2020.101553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
60 Joshi R, Kumar A, Manral S, Sinha R, Arora S, Sharma A, Goel S, Kalra N, Chatterji S, Dwarakanath BS, Rawat DS, Depass AL, Rohil V, Saluja D, Parmar VS, Prasad AK, Raj HG. Calreticulin transacetylase mediated upregulation of thioredoxin by 7,8-diacetoxy-4-methylcoumarin enhances the antioxidant potential and the expression of vascular endothelial growth factor in peripheral blood mononuclear cells. Chem Biol Interact 2013;206:327-36. [PMID: 24103856 DOI: 10.1016/j.cbi.2013.09.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
61 Nasoohi S, Parveen K, Ishrat T. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers. J Alzheimers Dis 2018;66:857-85. [PMID: 30372683 DOI: 10.3233/JAD-180735] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
62 Chan JY, Chan SH. Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: A lesson learnt from DJ-1. Pharmacol Ther 2015;156:69-74. [PMID: 26432617 DOI: 10.1016/j.pharmthera.2015.09.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
63 Kahlhofer J, Leon S, Teis D, Schmidt O. The α-arrestin family of ubiquitin ligase adaptors links metabolism with selective endocytosis. Biol Cell 2021;113:183-219. [PMID: 33314196 DOI: 10.1111/boc.202000137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
64 Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 2006;71:551-64. [PMID: 16337153 DOI: 10.1016/j.bcp.2005.10.044] [Cited by in Crossref: 361] [Cited by in F6Publishing: 329] [Article Influence: 21.2] [Reference Citation Analysis]
65 Mochizuki M, Kwon YW, Yodoi J, Masutani H. Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway. Antioxid Redox Signal 2009;11:2957-71. [PMID: 19622016 DOI: 10.1089/ars.2009.2623] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
66 Williams KJ, Wu X. Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward. Atherosclerosis 2016;247:225-82. [PMID: 26967715 DOI: 10.1016/j.atherosclerosis.2016.02.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
67 Kang H, Jeon YH, Ham M, Ko K, Kim IY. Compensatory Protection of Thioredoxin-Deficient Cells from Etoposide-Induced Cell Death by Selenoprotein W via Interaction with 14-3-3. Int J Mol Sci 2021;22:10338. [PMID: 34638679 DOI: 10.3390/ijms221910338] [Reference Citation Analysis]
68 Braunstein J, Autschbach F, Giese T, Lasitschka F, Heidtmann A, Sido B, Funke B, Reiser C, Schröder AJ, Nebl G, Samstag Y, Meuer SC. Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes. Clin Exp Immunol 2008;151:496-504. [PMID: 18234058 DOI: 10.1111/j.1365-2249.2007.03562.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
69 Smith SL, Pitt AR, Spickett CM. Approaches to Investigating the Protein Interactome of PTEN. J Proteome Res 2021;20:60-77. [PMID: 33074689 DOI: 10.1021/acs.jproteome.0c00570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Xie W, Ma W, Liu P, Zhou F. Overview of thioredoxin system and targeted therapies for acute leukemia. Mitochondrion 2019;47:38-46. [DOI: 10.1016/j.mito.2019.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
71 Peng X, Giménez-Cassina A, Petrus P, Conrad M, Rydén M, Arnér ES. Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness. Sci Rep 2016;6:28080. [PMID: 27346647 DOI: 10.1038/srep28080] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
72 Verrastro I, Tveen-jensen K, Woscholski R, Spickett CM, Pitt AR. Reversible oxidation of phosphatase and tensin homolog (PTEN) alters its interactions with signaling and regulatory proteins. Free Radical Biology and Medicine 2016;90:24-34. [DOI: 10.1016/j.freeradbiomed.2015.11.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
73 Haas B, Schütte L, Wos-Maganga M, Weickhardt S, Timmer M, Eckstein N. Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells. Int J Mol Sci 2018;19:E2874. [PMID: 30248944 DOI: 10.3390/ijms19102874] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
74 Powis G, Wipf P, Lynch SM, Birmingham A, Kirkpatrick DL. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase. Mol Cancer Ther 2006;5:630-6. [PMID: 16546977 DOI: 10.1158/1535-7163.MCT-05-0487] [Cited by in Crossref: 53] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
75 Hwang J, Suh HW, Jeon YH, Hwang E, Nguyen LT, Yeom J, Lee SG, Lee C, Kim KJ, Kang BS, Jeong JO, Oh TK, Choi I, Lee JO, Kim MH. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun 2014;5:2958. [PMID: 24389582 DOI: 10.1038/ncomms3958] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
76 Nekrasov V, Ludwig AA, Jones JD. CITRX thioredoxin is a putative adaptor protein connecting Cf-9 and the ACIK1 protein kinase during the Cf-9/Avr9- induced defence response. FEBS Letters 2006;580:4236-41. [DOI: 10.1016/j.febslet.2006.06.077] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
77 Mukherjee A, Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol. 2008;81 Spec No 1:S57-S68. [PMID: 18819999 DOI: 10.1259/bjr/34180435] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
78 Kondo N, Nakamura H, Masutani H, Yodoi J. Redox regulation of human thioredoxin network. Antioxid Redox Signal. 2006;8:1881-1890. [PMID: 16987040 DOI: 10.1089/ars.2006.8.1881] [Cited by in Crossref: 131] [Cited by in F6Publishing: 117] [Article Influence: 8.7] [Reference Citation Analysis]
79 D'Annunzio V, Perez V, Boveris A, Gelpi RJ, Poderoso JJ. Role of thioredoxin-1 in ischemic preconditioning, postconditioning and aged ischemic hearts. Pharmacol Res 2016;109:24-31. [PMID: 26987940 DOI: 10.1016/j.phrs.2016.03.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
80 Watson WH. Molecular Mechanisms in Arsenic Toxicity. Elsevier; 2015. pp. 35-75. [DOI: 10.1016/b978-0-12-802229-0.00003-7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
81 Chutkow WA, Patwari P, Yoshioka J, Lee RT. Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production. Journal of Biological Chemistry 2008;283:2397-406. [DOI: 10.1074/jbc.m708169200] [Cited by in Crossref: 124] [Cited by in F6Publishing: 82] [Article Influence: 8.9] [Reference Citation Analysis]
82 Engman L, Mcnaughton M, Gajewska M, Kumar S, Birmingham A, Powis G. Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds: . Anti-Cancer Drugs 2006;17:539-44. [DOI: 10.1097/00001813-200606000-00007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
83 Kotelevets L, Scott MGH, Chastre E. Targeting PTEN in Colorectal Cancers. In: Jordan P, editor. Targeted Therapy of Colorectal Cancer Subtypes. Cham: Springer International Publishing; 2018. pp. 55-73. [DOI: 10.1007/978-3-030-02771-1_5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
84 Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 2006;281:21884-91. [PMID: 16766796 DOI: 10.1074/jbc.M600427200] [Cited by in Crossref: 193] [Cited by in F6Publishing: 119] [Article Influence: 12.1] [Reference Citation Analysis]
85 Fortin JS, Côté M, Lacroix J, Desjardins M, Petitclerc É, C.-gaudreault R. Selective alkylation of βII-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents. Bioorganic & Medicinal Chemistry 2008;16:7277-90. [DOI: 10.1016/j.bmc.2008.06.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
86 Shearn CT, Mercer KE, Orlicky DJ, Hennings L, Smathers-McCullough RL, Stiles BL, Ronis MJ, Petersen DR. Short term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout mice. PLoS One 2014;9:e96553. [PMID: 24818992 DOI: 10.1371/journal.pone.0096553] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
87 Ago T, Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal 2007;9:679-87. [PMID: 17419666 DOI: 10.1089/ars.2007.1529] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
88 Ogata FT, Batista WL, Sartori A, Gesteira TF, Masutani H, Arai RJ, Yodoi J, Stern A, Monteiro HP. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization. PLoS One 2013;8:e84588. [PMID: 24376827 DOI: 10.1371/journal.pone.0084588] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
89 Burke-Gaffney A, Callister ME, Nakamura H. Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci. 2005;26:398-404. [PMID: 15990177 DOI: 10.1016/j.tips.2005.06.005] [Cited by in Crossref: 150] [Cited by in F6Publishing: 145] [Article Influence: 9.4] [Reference Citation Analysis]
90 Lu T, Zong M, Fan S, Lu Y, Yu S, Fan L. Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes. Clin Rheumatol 2018;37:117-25. [PMID: 28914370 DOI: 10.1007/s10067-017-3832-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
91 Billiet L, Furman C, Cuaz-Pérolin C, Paumelle R, Raymondjean M, Simmet T, Rouis M. Thioredoxin-1 and its natural inhibitor, vitamin D3 up-regulated protein 1, are differentially regulated by PPARalpha in human macrophages. J Mol Biol 2008;384:564-76. [PMID: 18848838 DOI: 10.1016/j.jmb.2008.09.061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
92 Sartelet H, Rougemont AL, Fabre M, Castaing M, Duval M, Fetni R, Michiels S, Beaunoyer M, Vassal G. Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Hum Pathol 2011;42:1727-39. [PMID: 21641013 DOI: 10.1016/j.humpath.2011.01.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
93 Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. Oncotarget 2015;6:25506-19. [PMID: 26325518 DOI: 10.18632/oncotarget.4635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
94 Mahmood DFD, Jguirim-Souissi I, Khadija EH, Blondeau N, Diderot V, Amrani S, Slimane MN, Syrovets T, Simmet T, Rouis M. Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis. J Biol Chem 2011;286:28858-66. [PMID: 21700710 DOI: 10.1074/jbc.M111.273292] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
95 Kim B, Hebert JM, Liu D, Auguste DT. A Lipid Targeting, pH‐Responsive Nanoemulsion Encapsulating a DNA Intercalating Agent and HDAC Inhibitor Reduces TNBC Tumor Burden. Adv Therap 2021;4:2000211. [DOI: 10.1002/adtp.202000211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Davis RA. Searching for causality of knocking out Txnip: is Txnip missing in action? Circ Res 2007;101:1216-8. [PMID: 18063816 DOI: 10.1161/CIRCRESAHA.107.165654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
97 Cui W, Hu SX, Tang ZY, Hu KQ. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anticancer Drugs. 2008;19:891-897. [PMID: 18766003 DOI: 10.1097/CAD.0b013e32830ef8ca] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
98 Mishra RR, Chaudhary JK, Rath PC. Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells. Mol Biol Rep 2012;39:7389-402. [PMID: 22311048 DOI: 10.1007/s11033-012-1571-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
99 Chae JS, Gil Hwang S, Lim D, Choi E. Thioredoxin-1 functions as a molecular switch regulating the oxidative stress-induced activation of MST1. Free Radical Biology and Medicine 2012;53:2335-43. [DOI: 10.1016/j.freeradbiomed.2012.10.527] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
100 Du ZD, Hu LT, Hu YT, Ma ZZ. The effects of sodium orthovanadate-induced phosphatase inhibition on rat retinal pigment epithelium cell activity. Cutan Ocul Toxicol 2010;29:261-8. [PMID: 20807114 DOI: 10.3109/15569527.2010.509851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
101 Kim RH, Mak TW. Tumours and tremors: how PTEN regulation underlies both. Br J Cancer. 2006;94:620-624. [PMID: 16495927 DOI: 10.1038/sj.bjc.6602994] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.5] [Reference Citation Analysis]
102 An N, Kang Y. Thioredoxin and hematologic malignancies. Adv Cancer Res 2014;122:245-79. [PMID: 24974184 DOI: 10.1016/B978-0-12-420117-0.00007-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
103 Tan A, Nakamura H, Kondo N, Tanito M, Kwon YW, Ahsan MK, Matsui H, Narita M, Yodoi J. Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice. Free Radic Res. 2007;41:861-869. [PMID: 17654042 DOI: 10.1080/10715760701199618] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
104 Yoshihara E. TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis. Antioxidants (Basel) 2020;9:E765. [PMID: 32824669 DOI: 10.3390/antiox9080765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
105 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
106 Nigro P, Dal Piaz F, Gallotta D, De Tommasi N, Belisario MA. Inhibition of the thioredoxin system is a basis for the antileukemic potential of 13-hydroxy-15-oxo-zoapatlin. Free Radic Biol Med 2008;45:875-84. [PMID: 18638547 DOI: 10.1016/j.freeradbiomed.2008.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
107 Ostrakhovitch EA, Semenikhin OA. The role of redox environment in neurogenic development. Arch Biochem Biophys 2013;534:44-54. [PMID: 22910298 DOI: 10.1016/j.abb.2012.08.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
108 Sweeney M, Coyle R, Kavanagh P, Berezin AA, Lo Re D, Zissimou GA, Koutentis PA, Carty MP, Aldabbagh F. Discovery of anti-cancer activity for benzo[1,2,4]triazin-7-ones: Very strong correlation to pleurotin and thioredoxin reductase inhibition. Bioorg Med Chem 2016;24:3565-70. [PMID: 27290691 DOI: 10.1016/j.bmc.2016.05.066] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
109 Kim YH, Coon A, Baker AF, Powis G. Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemother Pharmacol 2011;68:405-13. [PMID: 21069338 DOI: 10.1007/s00280-010-1500-0] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
110 Hadri KE, Mahmood DFD, Couchie D, Jguirim-souissi I, Genze F, Diderot V, Syrovets T, Lunov O, Simmet T, Rouis M. Thioredoxin-1 Promotes Anti-Inflammatory Macrophages of the M2 Phenotype and Antagonizes Atherosclerosis. ATVB 2012;32:1445-52. [DOI: 10.1161/atvbaha.112.249334] [Cited by in Crossref: 58] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
111 Wu C, Parrott AM, Fu C, Liu T, Marino SM, Gladyshev VN, Jain MR, Baykal AT, Li Q, Oka S, Sadoshima J, Beuve A, Simmons WJ, Li H. Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal 2011;15:2565-604. [PMID: 21453190 DOI: 10.1089/ars.2010.3831] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 7.5] [Reference Citation Analysis]
112 Cahill CM, Rogers JT, Walker WA. The role of phosphoinositide 3-kinase signaling in intestinal inflammation. J Signal Transduct 2012;2012:358476. [PMID: 22570785 DOI: 10.1155/2012/358476] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
113 Song Z, Saghafi N, Gokhale V, Brabant M, Meuillet EJ. Regulation of the activity of the tumor suppressor PTEN by thioredoxin in Drosophila melanogaster. Exp Cell Res 2007;313:1161-71. [PMID: 17316609 DOI: 10.1016/j.yexcr.2007.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
114 Lee S, Kim SM, Lee RT. Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid Redox Signal 2013;18:1165-207. [PMID: 22607099 DOI: 10.1089/ars.2011.4322] [Cited by in Crossref: 234] [Cited by in F6Publishing: 209] [Article Influence: 23.4] [Reference Citation Analysis]
115 Di Pietro R, Fang H, Fields K, Miller S, Flora M, Petricoin E, Dveksler G, Rana R, Grimley P. Peroxiredoxin Genes are Not Induced in Myeloid Leukemia Cells Exposed to Ionizing Radiation. Int J Immunopathol Pharmacol 2006;19:517-24. [DOI: 10.1177/039463200601900307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
116 Jasek-Gajda E, Jurkowska H, Jasińska M, Lis GJ. Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia Cells. Antioxidants (Basel) 2020;9:E633. [PMID: 32709140 DOI: 10.3390/antiox9070633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
117 Kaimul AM, Nakamura H, Masutani H, Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med. 2007;43:861-868. [PMID: 17697931 DOI: 10.1016/j.freeradbiomed.2007.05.032] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
118 Young D, Pedre B, Ezeriņa D, De Smet B, Lewandowska A, Tossounian MA, Bodra N, Huang J, Astolfi Rosado L, Van Breusegem F, Messens J. Protein Promiscuity in H2O2 Signaling. Antioxid Redox Signal 2019;30:1285-324. [PMID: 29635930 DOI: 10.1089/ars.2017.7013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
119 Javadi A, Deevi RK, Evergren E, Blondel-Tepaz E, Baillie GS, Scott MG, Campbell FC. PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex. Elife 2017;6:e24578. [PMID: 28749339 DOI: 10.7554/eLife.24578] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
120 Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, Manevich Y, Beeson C, Neumann CA. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 2009;28:1505-1517. [PMID: 19369943 DOI: 10.1038/emboj.2009.101] [Cited by in Crossref: 231] [Cited by in F6Publishing: 234] [Article Influence: 17.8] [Reference Citation Analysis]
121 Bonifant CL, Kim JS, Waldman T. NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN. J Cell Biochem 2007;102:878-85. [PMID: 17786934 DOI: 10.1002/jcb.21518] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
122 Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Identification of Thioredoxin-Interacting Protein 1 as a Hypoxia-Inducible Factor 1α-Induced Gene in Pancreatic Cancer. Pancreas 2008;36:178-86. [DOI: 10.1097/mpa.0b013e31815929fe] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
123 Tian Y, Ge Z, Xu M, Ge X, Zhao M, Ding F, Yin J, Wang X, You Y, Shi Z, Qian X. Diallyl trisulfide sensitizes radiation therapy on glioblastoma through directly targeting thioredoxin 1. Free Radic Biol Med 2022:S0891-5849(22)00502-0. [PMID: 35921994 DOI: 10.1016/j.freeradbiomed.2022.07.019] [Reference Citation Analysis]
124 Cebula M, Schmidt EE, Arnér ES. TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Antioxid Redox Signal 2015;23:823-53. [PMID: 26058897 DOI: 10.1089/ars.2015.6378] [Cited by in Crossref: 151] [Cited by in F6Publishing: 138] [Article Influence: 21.6] [Reference Citation Analysis]
125 Xu J, Yang X, Deshmukh D, Chen H, Fang S, Qiu Y. The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells. Cells 2020;9:E1094. [PMID: 32354165 DOI: 10.3390/cells9051094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Yeo EJ, Eum WS, Yeo HJ, Choi YJ, Sohn EJ, Kwon HJ, Kim DW, Kim DS, Cho SW, Park J, Han KH, Lee KW, Park JK, Shin MJ, Choi SY. Protective Role of Transduced Tat-Thioredoxin1 (Trx1) against Oxidative Stress-Induced Neuronal Cell Death via ASK1-MAPK Signal Pathway. Biomol Ther (Seoul) 2021;29:321-30. [PMID: 33436533 DOI: 10.4062/biomolther.2020.154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Cardenas-Rodriguez M, Tokatlidis K. Cytosolic redox components regulate protein homeostasis via additional localisation in the mitochondrial intermembrane space. FEBS Lett 2017;591:2661-70. [PMID: 28746987 DOI: 10.1002/1873-3468.12766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
128 Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M. The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal 2013;19:1266-303. [PMID: 23244617 DOI: 10.1089/ars.2012.4757] [Cited by in Crossref: 197] [Cited by in F6Publishing: 182] [Article Influence: 21.9] [Reference Citation Analysis]
129 Meng Z, Jia LF, Gan YH. PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition. Oncogene 2016;35:2333-44. [PMID: 26279303 DOI: 10.1038/onc.2015.293] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
130 Gericke A, Munson M, Ross AH. Regulation of the PTEN phosphatase. Gene 2006;374:1-9. [DOI: 10.1016/j.gene.2006.02.024] [Cited by in Crossref: 139] [Cited by in F6Publishing: 137] [Article Influence: 8.7] [Reference Citation Analysis]
131 Sadeghirizi A, Yazdanparast R, Aghazadeh S. Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction. Tumor Biol 2016;37:6737-47. [DOI: 10.1007/s13277-015-4424-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
132 Zhang Y, Roh YJ, Han SJ, Park I, Lee HM, Ok YS, Lee BC, Lee SR. Role of Selenoproteins in Redox Regulation of Signaling and the Antioxidant System: A Review. Antioxidants (Basel) 2020;9:E383. [PMID: 32380763 DOI: 10.3390/antiox9050383] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
133 Ago T, Sadoshima J. Thioredoxin and ventricular remodeling. J Mol Cell Cardiol 2006;41:762-73. [PMID: 17007870 DOI: 10.1016/j.yjmcc.2006.08.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 4.0] [Reference Citation Analysis]
134 Shearn CT, Smathers RL, Backos DS, Reigan P, Orlicky DJ, Petersen DR. Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis. Free Radic Biol Med. 2013;65:680-692. [PMID: 23872024 DOI: 10.1016/j.freeradbiomed.2013.07.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
135 Zhang J, Li X, Han X, Liu R, Fang J. Targeting the Thioredoxin System for Cancer Therapy. Trends Pharmacol Sci 2017;38:794-808. [PMID: 28648527 DOI: 10.1016/j.tips.2017.06.001] [Cited by in Crossref: 146] [Cited by in F6Publishing: 149] [Article Influence: 29.2] [Reference Citation Analysis]
136 Zhang H, Du Y, Zhang X, Lu J, Holmgren A. Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal. Antioxid Redox Signal 2014;21:669-81. [PMID: 24295294 DOI: 10.1089/ars.2013.5499] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]